Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT

Clinical trial NCT04602377 · RECRUITING

Trial details

NCT number: NCT04602377
Sponsor: ARCAGY/ GINECO GROUP
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Ovarian Carcinoma

Start date: 2021-08-04
Primary completion: 2026-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.